levodopa has been researched along with physostigmine in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (79.41) | 18.7374 |
| 1990's | 2 (5.88) | 18.2507 |
| 2000's | 2 (5.88) | 29.6817 |
| 2010's | 3 (8.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Minderhoud, JM; van Weerden, TW; van Woerkom, TC | 1 |
| Harrewijn, P | 1 |
| Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
| Anisman, H; Remington, G; Sklar, LS | 1 |
| Fujimura, Y; Ikeda, Y; Iwasaki, T; Koide, T; Matsushita, H; Nagashima, R; Shindo, M; Shiraki, Y; Suzuki, S; Takano, N | 1 |
| Casey, DE | 1 |
| Battista, AF; Goldstein, M; Miyamoto, T | 1 |
| Carolei, A; Margotta, V; Palladini, G | 1 |
| Agnoli, A; Squitieri, G | 1 |
| Lakke, JP; Lindeboom, SF | 1 |
| Lai, C; Tolosa, ES | 1 |
| Anlezark, GM; Marsden, CD; Meldrum, BS | 1 |
| Casey, DE; Denney, D | 1 |
| Aiello-Malmberg, P; Bartolini, A; Bartolini, R; Galli, A | 1 |
| Ishikawa, T; Yamamoto, M | 1 |
| Baran, L; Maj, J; Sowińska, H | 1 |
| Fujiwara, M; Inoue, K; Ueki, S | 1 |
| Mees, W; Minderhoud, JM; van Weerden, TW; van Woerkom, TC | 1 |
| Schmidt, RT; Spehlmann, R; Stahl, SM | 1 |
| Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S | 1 |
| el-Sawaf, HA; Puri, VN; Rao, KV | 1 |
| Jenner, P; Marsden, CD; Rupniak, NM | 1 |
| Genovese, N; Klawans, HL | 1 |
| Bowman, RE; Levin, ED; Vuchetich, J; Wegert, S | 1 |
| Boggan, WO; Schlesinger, K | 1 |
| Bergmann, KJ; Clough, CG; Yahr, MD | 1 |
| Ghosh, MN; Gopalakrishnan, V; Pillai, NP; Ramaswamy, S | 1 |
| Gottschal, T; Minderhoud, JM; Nicolai, G; van Woerkom, TC | 1 |
| Liang, YX; Zheng, YX | 1 |
4 review(s) available for levodopa and physostigmine
| Article | Year |
|---|---|
Deanol in the management of involuntary movement disorders: a review.
Topics: Acetylcholine; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Models, Neurological; Movement Disorders; Parkinson Disease; Physostigmine; Research Design; Time Factors | 1977 |
[Memory, biochemical and pharmacological problems].
Topics: Amantadine; Amphetamine; Brain; Catecholamines; Humans; Levodopa; Memory, Short-Term; Paired-Associate Learning; Physostigmine; Reserpine | 1977 |
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease Models, Animal; Drug Synergism; Dystonia; Fluphenazine; Haloperidol; Histamine H1 Antagonists; Levodopa; Mastication; Methyltyrosines; Movement Disorders; Parasympatholytics; Physostigmine; Primates; Rats | 1986 |
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
5 trial(s) available for levodopa and physostigmine
| Article | Year |
|---|---|
Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias.
Topics: Aged; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Physostigmine; Placebos | 1978 |
Meige disease: striatal dopaminergic preponderance.
Topics: Aged; Apomorphine; Basal Ganglia; Blepharospasm; Clinical Trials as Topic; Diagnosis, Differential; Eyelid Diseases; Facial Muscles; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Physostigmine; Placebos | 1979 |
Pharmacological characterization of tardive dyskinesia.
Topics: Adult; Benztropine; Clinical Trials as Topic; Deanol; Dopamine; Droperidol; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Physostigmine; Placebos; Time Factors | 1977 |
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
Neurotransmitters in the treatment of patients with severe head injuries.
Topics: Adolescent; Adult; Brain Injuries; Child; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurocognitive Disorders; Physostigmine; Prognosis; Verbal Behavior | 1982 |
26 other study(ies) available for levodopa and physostigmine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
On the nature of brain stem disorders in severe head injured patients. II. A study on caloric vestibular reactions and neurotransmitter treatment.
Topics: Akinetic Mutism; Brain Injuries; Brain Stem; Caloric Tests; Child, Preschool; Coma; Consciousness; Humans; Levodopa; Middle Aged; Neurotransmitter Agents; Physostigmine; Time Factors; Vestibular Function Tests | 1976 |
Role of monoamine metabolism in wing dimorphism of the aphid Myzus persicae.
Topics: Animals; Aphids; Autonomic Agents; Dopamine; Fenclonine; Isoproterenol; Levodopa; Methyldopa; Norepinephrine; Physostigmine; Reserpine; Tryptamines; Wings, Animal | 1976 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance.
Topics: Animals; Avoidance Learning; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain Chemistry; Dopamine; Electroshock; Female; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Scopolamine; Serotonin; Sympathetic Nervous System | 1979 |
Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
Topics: Acetylcholine; Amphetamine; Animals; Antidepressive Agents; Barbiturates; Behavior, Animal; Biogenic Amines; Blood Pressure; Brain Chemistry; Catecholamines; Cats; Dogs; Electroencephalography; Female; Guinea Pigs; Haplorhini; In Vitro Techniques; Indazoles; Levodopa; Macaca fascicularis; Male; Mice; Muscle Contraction; Muscle, Smooth; Physostigmine; Pyrazoles; Rabbits; Rats; Reserpine; Tremorine | 1979 |
Modification of involuntary movements by centrally acting drugs.
Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline | 1975 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
Acute dystonia as an idiosyncratic response to neuroleptics in baboons.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Papio; Parasympatholytics; Physostigmine; Pimozide; Receptors, Dopamine; Reserpine; Syndrome; Tranquilizing Agents | 1977 |
Effects of morphine, physostigmine and raphe nuclei stimulation on 5-hydroxytryptamine release from the cerebral cortex of the cat.
Topics: Animals; Brain Stem; Cats; Cerebral Cortex; Dihydroxyphenylalanine; Electric Stimulation; Electroencephalography; Female; Levodopa; Male; Morphine; Physostigmine; Raphe Nuclei; Rats; Serotonin; Species Specificity | 1979 |
Involvement of the cholinergic mechanism in depression of the caudate spindle.
Topics: Animals; Atropine; Cats; Caudate Nucleus; Depression, Chemical; Female; Levodopa; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Physostigmine; Reticular Formation | 1979 |
Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
Topics: Amantadine; Animals; Anthracenes; Catalepsy; Drug Synergism; Female; Humans; Levodopa; Male; Physostigmine; Piperidines; Rats; Receptors, Drug; Reserpine; Serotonin; Tranquilizing Agents | 1976 |
[Behavioral pharmacology of a new antidepressant, lopramine].
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Avoidance Learning; Blepharoptosis; Body Temperature; Catalepsy; Dibenzazepines; Drug Synergism; Emotions; Humans; Imipramine; Lethal Dose 50; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Muscle Relaxation; Oxotremorine; Physostigmine; Rats; Stereotyped Behavior | 1976 |
Electro-oculographic study of caloric vestibular reactions in patients with severe head injuries.
Topics: Adolescent; Adult; Brain Injuries; Caloric Tests; Child; Child, Preschool; Coma; Electrooculography; Humans; Levodopa; Middle Aged; Physostigmine; Prognosis; Time Factors; Unconsciousness; Vestibular Function Tests | 1975 |
A pharmacologic study of the stiff-man syndrome. Correlation of clinical symptoms with urinary 3-methoxy-4-hydroxy-phenyl glycol excretion.
Topics: Diazepam; Glycine; Glycols; Homovanillic Acid; Humans; Levodopa; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Muscle Rigidity; Normetanephrine; Physostigmine; Spasm; Syndrome; Vanilmandelic Acid | 1975 |
[Behavior pharmacology of maprotiline, a new antidepressant].
Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Escape Reaction; Eyelids; Haloperidol; Humans; Imipramine; Levodopa; Maprotiline; Methamphetamine; Mice; Motor Activity; Oxotremorine; Physostigmine; Rats; Reserpine; Sleep; Tetrabenazine | 1975 |
Further studies on the neuroleptic profile of manassantin A.
Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Blepharoptosis; Body Temperature; Catalepsy; Furans; Haloperidol; In Vitro Techniques; Levodopa; Lignans; Male; Mice; Norepinephrine; Pentobarbital; Physostigmine; Plants, Medicinal; Stereotyped Behavior | 1990 |
Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys.
Topics: Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition Disorders; Dopamine; Haloperidol; Lead Poisoning; Levodopa; Macaca mulatta; Physostigmine; Scopolamine; Sulpiride | 1987 |
Pharmacological correlates of ECS induced disruption of a passive avoidance task in mice.
Topics: 5-Hydroxytryptophan; Acetates; Animals; Atropine; Avoidance Learning; Electroshock; Female; Levodopa; Male; Memory; Mice; Mice, Inbred C57BL; Physostigmine; Reaction Time; Reserpine; Seizures; Thiosemicarbazones | 1974 |
Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration.
Topics: Acetylcholine; Adult; Aged; Antiparkinson Agents; Apomorphine; Brain; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Physostigmine; Time Factors | 1984 |
Effect of cholinergic agonists and antagonists on jumping behaviour induced by morphine and L-dopa in mice.
Topics: Animals; Atropine; Atropine Derivatives; Levodopa; Male; Mice; Morphine; Motor Activity; Neostigmine; Parasympatholytics; Parasympathomimetics; Physostigmine | 1984 |
The antagonistic effects of L-dopa and eserine on Al-induced neurobehavioral deficits in rats.
Topics: Aluminum; Animals; Body Weight; Cholinesterase Inhibitors; Dopamine Agents; Drug Evaluation, Preclinical; Female; Levodopa; Maze Learning; Memory; Neurotoxins; Physostigmine; Rats; Rats, Sprague-Dawley | 1998 |